VTRLY OTC
Vitrolife AB (publ)
1W: +0.0%
1M: +0.0%
3M: -13.9%
YTD: -36.9%
1Y: -36.7%
3Y: -19.4%
5Y: -62.2%
$9.50
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$635M
-34.2% ▼
5Y CAGR: +12.2%
Capital Expenditures
$254M
-175.9% ▼
5Y CAGR: +66.1%
Free Cash Flow
$343M
-62.2% ▼
5Y CAGR: +0.4%
Dividends Paid
$140M
-3.7% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$326M
-219.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $460M | $537M | -$3.9B | $674M | -$4.9B |
| Depreciation & Amort. | $109M | $396M | $425M | $0 | $0 |
| Stock-Based Comp. | $5M | $10M | $17M | $0 | $0 |
| Change in Working Capital | -$10M | -$175M | -$119M | -$68M | -$90M |
| Other Non-Cash Items | $2M | $7M | $4.3B | $301M | $5.6B |
| Operating Cash Flow | $384M | $636M | $757M | $907M | $635M |
| — Investing Activities — | |||||
| Capital Expenditures | -$62M | -$87M | -$67M | $0 | $0 |
| Acquisitions (Net) | -$6.5B | -$42M | -$10M | -$179M | -$31M |
| Investment Purchases | -$382K | $0 | $0 | $0 | $0 |
| Investment Sales | $16M | $0 | $0 | $0 | $0 |
| Other Investing | -$6M | -$15M | -$47M | -$198M | -$271M |
| Investing Cash Flow | -$6.5B | -$144M | -$124M | -$377M | -$302M |
| — Financing Activities — | |||||
| Net Debt Issuance | $2.4B | -$430M | -$153M | -$104M | -$346M |
| Stock Repurchased | -$23M | $0 | $0 | $0 | $0 |
| Dividends Paid | -$87M | -$109M | -$115M | -$135M | -$140M |
| Other Financing | -$51M | -$43M | -$32M | -$47M | -$67M |
| Financing Cash Flow | $5.7B | -$582M | -$300M | -$286M | -$553M |
| Net Change in Cash | -$343M | -$52M | $283M | $274M | -$326M |
| Cash End of Period | $630M | $578M | $861M | $1.1B | $809M |
| Free Cash Flow | $322M | $549M | $638M | $907M | $343M |